Form 4: Director Puckett Acquires PROCEPT BioRobotics Stock

Director Dan Puckett acquired restricted stock units and a stock option for PROCEPT BioRobotics Corp. shares.

Summary

• Director Dan Puckett acquired 3,315 shares of Common Stock through restricted stock units (RSUs) on June 9, 2026.
• These RSUs represent a contingent right to receive one share of Common Stock per unit.
• The RSUs are set to vest in full on the one-year anniversary of the grant date or the next annual meeting, whichever comes first, contingent on continued service.
• Additionally, Puckett was granted a stock option to purchase 5,853 shares of Common Stock at an exercise price of $28.78.
• This stock option also vests in full on the earlier of the one-year anniversary of the grant date or the next annual meeting, subject to continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents standard compensation and equity grants to a director rather than a significant financial event or strategic shift.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The grant of RSUs and stock options aligns management's interests with shareholders.

Risks

• Vesting of RSUs and stock options is contingent on continued service, meaning forfeiture is possible if the director leaves the company before the vesting date.
• The stock option has an exercise price of $28.78, implying that the stock price needs to exceed this level for the option to be profitable.

Future Outlook

The vesting schedule for both the RSUs and the stock option indicates a one-year horizon or until the next annual meeting, suggesting management's focus on near-to-medium term performance and retention.

Industry Context

StockSavvy.ai notes that insider grants of equity, such as RSUs and stock options, are common in the biotechnology and medical device sectors as a method to attract, retain, and incentivize key personnel, particularly directors and executives.

Stakeholder Impact

• Shareholders: The acquisition of stock by a director may be viewed positively as a sign of commitment, but the dilutive effect of future share issuance upon vesting should be considered.
• Employees: Standard compensation practice that aligns director incentives with company performance.
• Management: Reinforces the use of equity-based compensation for director retention and motivation.

Next Steps

• Vesting of RSUs and stock options on or before the next annual meeting or one-year anniversary of the grant date, contingent on continued service.

Key Dates

Keywords

PROCEPT BioRobotics Corp, PRCT, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Director Compensation, Beneficial Ownership